[December 29, 2017]

Blood Screening Market - Expected to Reach $3.9 Billion by 2023 - Research and Markets

The "Blood Screening - Global Market Outlook (2017-2023)" report has been added to Research and Markets' offering.

The Global Blood Screening market is expected to grow from $1.84 billion in 2016 to reach $3.97 billion by 2023 with a CAGR of 11.6%.

Growing incidence of infectious diseases, rise in consciousness of donating blood, and increase in health care awareness are some of the factors boosting the market growth. In addition, technological advancements in blood screening techniques, increasing investments in research & development are some of the other factors fuelling the market growth during the forecast period. However, threat from substitute techniques, initial investment costs are some of the restraints limiting the market growth.

Blood Screening tests are the foundation of a successful health care system, providing critical information that health care provider and patients need to make the right medical decisions. Blood screening often provide objective, quantitative measurements that inform every stage of care-prevention, detection, diagnosis, treatment, and successful management of health conditions.

North America accounted for the largest share in global blood screening market followed by Europe. Growth of the region is attributed to existence of major companies and devloped healthcare infrastructure. Asia Pacific is expected to witness huge growth due to developing economies, raising health care expenditure, and increasing demand for blood screening in emerging countries such as China, Japan and India.

Technologies Covered:

• Next-generation Sequencing (NGS)
• Rapid Tests
• Western Blot Assay
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Nucleic Acid Test (NAT)

Product & Service Types Covered:

• Software and Services
• Instruments
• Reagents & Kits

Applications Covered:

• Diabetes Blood Testing
• Cardiovascular Disease Blood Testing
• Cancer Blood Testing
• Blood Disorder Blood Testing
• Autoimmune Disease And Food Allergy Testing
• Pregnancy Blood Testing
• Liver Disorder Blood Testing
• Kidney Disorder Blood Testing
• Home-Monitoring Blood Testing
• Fertility Blood Testing

End Users Covered:

• Blood Banks
• Hospitals

Companies Mentioned

• Abbott Laboratories
• Alere Inc.
• Apex (News - Alert) Biotechnology Corp.
• Beckman Coulter (A Subsidiary of Danaher Corporation)
• Becton, Dickinson and Company
• Biomrieux
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche
• Grifols
• Hem

Key Topics Covered:

1. Executive Summary

2. Preface

3. Market Trend Analysis

4. Porters Five Force Analysis

5. Global Blood Screening Market, By Technology

6. Global Blood Screening Market, By Product & Service

7. Global Blood Screening Market, By Application

8. Global Blood Screening Market, By End User

9. Global Blood Screening Market, By Geography

10. Key Developments

11. Company Profiling

For more information about this report visit https://www.researchandmarkets.com/research/f4qk5m/blood_screening

View source version on businesswire.com: http://www.businesswire.com/news/home/20171229005165/en/

[ Back To TMCnet.com's Homepage ]